Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1242308.RAdpSKVqxI1OiUMy3EE5lsrxDUXOSsm1iyqrnrOOhLpww130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1242308.RAdpSKVqxI1OiUMy3EE5lsrxDUXOSsm1iyqrnrOOhLpww130_assertion type Assertion NP1242308.RAdpSKVqxI1OiUMy3EE5lsrxDUXOSsm1iyqrnrOOhLpww130_head.
- NP1242308.RAdpSKVqxI1OiUMy3EE5lsrxDUXOSsm1iyqrnrOOhLpww130_assertion description "[In this study, HepG2 cells were used to investigate the role of HSD17B4 in the proliferation of liver cancer cells treated with the NF-?B activator, tumor necrosis factor-alpha (TNF-?), with the inhibitor of NF-?B activation, pyrrolidinedithiocarbamate (PDTC), or with a related specific siRNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1242308.RAdpSKVqxI1OiUMy3EE5lsrxDUXOSsm1iyqrnrOOhLpww130_provenance.
- NP1242308.RAdpSKVqxI1OiUMy3EE5lsrxDUXOSsm1iyqrnrOOhLpww130_assertion evidence source_evidence_literature NP1242308.RAdpSKVqxI1OiUMy3EE5lsrxDUXOSsm1iyqrnrOOhLpww130_provenance.
- NP1242308.RAdpSKVqxI1OiUMy3EE5lsrxDUXOSsm1iyqrnrOOhLpww130_assertion SIO_000772 25448063 NP1242308.RAdpSKVqxI1OiUMy3EE5lsrxDUXOSsm1iyqrnrOOhLpww130_provenance.
- NP1242308.RAdpSKVqxI1OiUMy3EE5lsrxDUXOSsm1iyqrnrOOhLpww130_assertion wasDerivedFrom befree-2016 NP1242308.RAdpSKVqxI1OiUMy3EE5lsrxDUXOSsm1iyqrnrOOhLpww130_provenance.
- NP1242308.RAdpSKVqxI1OiUMy3EE5lsrxDUXOSsm1iyqrnrOOhLpww130_assertion wasGeneratedBy ECO_0000203 NP1242308.RAdpSKVqxI1OiUMy3EE5lsrxDUXOSsm1iyqrnrOOhLpww130_provenance.